Loading data
CGNXNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 994.36 m USD | 914.52 m USD | 837.55 m USD | 1.01 bn USD | 1.04 bn USD |
| Cost of revenue | 328.97 m USD | 288.72 m USD | 236.31 m USD | 284.19 m USD | 277.27 m USD |
| Gross profit | 665.39 m USD | 625.79 m USD | 601.24 m USD | 721.91 m USD | 759.83 m USD |
| Research and development expense | 138.97 m USD | 139.82 m USD | 139.4 m USD | 141.13 m USD | 135.37 m USD |
| Selling, general and administrative expense | 363.86 m USD | 370.91 m USD | 339.14 m USD | 312.11 m USD | 309.35 m USD |
| Operating profit | 162.57 m USD | 115.07 m USD | 130.7 m USD | 246.23 m USD | 315.1 m USD |
| Profit before tax | 182.8 m USD | 131.49 m USD | 135.35 m USD | 250.7 m USD | 318.9 m USD |
| Income tax expense | 68.36 m USD | 25.32 m USD | 22.11 m USD | 35.17 m USD | 39.02 m USD |
| Net income (reported basis) | 114.44 m USD | 106.17 m USD | 113.23 m USD | 215.53 m USD | 279.88 m USD |
| Basic earnings per share | 0.68 USD/share | 0.62 USD/share | 0.66 USD/share | 1.24 USD/share | 1.59 USD/share |
| Diluted earnings per share | 0.68 USD/share | 0.62 USD/share | 0.65 USD/share | 1.23 USD/share | 1.56 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.